Pendle MP backs Barnoldswick brain tumour campaigner Rachel

Rachel Wilson at protest
Rachel Wilson at protest
Share this article

A WOMAN who travelled to London as part of a delegation to ask MPs to use their positions in Parliament to urge the Government to do more in the fight against brain tumours has said the day was a “huge success”.

Rachel Wilson, from Barnoldswick, whose father, Foulridge farmer Andrew, died four months after diagnosis of a high-grade inoperable brain tumour at Christmas, joined patients, carers, scientists and doctors to tell MPs that brain tumour research was not getting the priority it deserved.

Andrew signs pledge

Andrew signs pledge

She met Pendle MP Andrew Stephenson to discuss the issue, and said: “I think he took me very seriously and I was pleased he signed our pledge to raise further awareness of brain tumours.”

Rachel, office manager for Brain Tumour Research and Support across Yorkshire, said: “We are calling on MPs not to forget brain tumours, and to do what they can to ensure a fairer, more proportionate amount of research spend is devoted to research.

“It is only by making advances in all three of these areas outcomes for people with brain tumours will start to improve.

“The first step in doing this is to get MPs and Government to understand just how many people are affected by brain tumours.”

As a first step, MPs are being encouraged to improve awareness about brain tumours by pledging to sign an Early Day Motion, signing an e-petition, to promote awareness of brain tumours in their constituencies, and take part in meetings of the All Party Brain Tumour Group.

Mr Stephenson said: “It was great to meet Rachel and talk about the work she is doing.

“I support the efforts made by the Brain Tumour Consortium to ensure existing medical guidelines should be followed to ensure early diagnosis and treatment for everyone affected by a brain tumour, that all those diagnosed should receive a consistently high standard of treatment and care across the UK, and there should be a significantly enhanced national programme of research which reflects the number of people affected by brain tumours.”